Last 12 months
Inside the activity.
1 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2021 Filed Mar 3, 2021 21:44 UTC |
Herendeen PaulEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 15,755 | $31.42 | $495,022.10 |
DisclosureSEC source: 0001127602-21-009199 · form4.xml · nonDerivative · entry 1 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,856 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:43 UTC |
Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l
|
Tax withholdingCommon Shares, No Par Value | 3,313 | $31.42 | $104,094.46 |
DisclosureSEC source: 0001127602-21-009196 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,250 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:33 UTC |
Eldessouky SamSVP, CHIEF ACCOUNTING OFFICER
|
Tax withholdingCommon Shares, No Par Value | 1,739 | $31.42 | $54,639.38 |
DisclosureSEC source: 0001127602-21-009157 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,313 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:30 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
Tax withholdingCommon Shares, No Par Value | 5,436 | $31.42 | $170,799.12 |
DisclosureSEC source: 0001127602-21-009144 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,975 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:26 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Tax withholdingCommon Shares, No Par Value | 5,367 | $31.42 | $168,631.14 |
DisclosureSEC source: 0001127602-21-009134 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,829 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 23:59 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 330 | $20.80 | $6,864.00 |
DisclosureSEC source: 0001127602-21-000250 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,501 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 23:58 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,802 | $20.80 | $37,481.60 |
DisclosureSEC source: 0001127602-21-000249 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,704 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 23:56 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,442 | $20.80 | $29,993.60 |
DisclosureSEC source: 0001127602-21-000248 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,440 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 23:54 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,622 | $20.80 | $33,737.60 |
DisclosureSEC source: 0001127602-21-000247 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,222 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:29 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
Tax withholdingCommon Shares, No Par Value | 3,224 | $20.61 | $66,446.64 |
DisclosureSEC source: 0001127602-20-031885 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,411 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 21:23 UTC |
Humphries William D.President, Ortho-Dermatologics
|
Exercise / conversionNon-qualified Stock Options (right To Purchase) · Derivative | 114,055 | $0.00 Strike: $14.38 | $0.00 |
DisclosureSEC source: 0001127602-20-030840 · form4.xml · derivative · entry 3 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 114,055 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 21:23 UTC |
Humphries William D.President, Ortho-Dermatologics
|
SaleCommon Shares, No Par Value | 114,055 | $19.87 | $2,266,398.31 |
DisclosureSEC source: 0001127602-20-030840 · form4.xml · nonDerivative · entry 2 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,035 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.80 to $19.82 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 21:23 UTC |
Humphries William D.President, Ortho-Dermatologics
|
Exercise / conversionCommon Shares, No Par Value | 114,055 | $14.38 | $1,640,110.90 |
DisclosureSEC source: 0001127602-20-030840 · form4.xml · nonDerivative · entry 1 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,090 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 21:50 UTC |
Humphries William D.President, Ortho-Dermatologics
|
Exercise / conversionNon-qualified Stock Options (right To Purchase) · Derivative | 13,663 | $0.00 Strike: $14.38 | $0.00 |
DisclosureSEC source: 0001127602-20-030120 · form4.xml · derivative · entry 9 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,055 Underlying: Common Shares, No Par Value · 13,663 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 21:50 UTC |
Humphries William D.President, Ortho-Dermatologics
|
SaleCommon Shares, No Par Value | 13,663 | $19.63 | $268,207.42 |
DisclosureSEC source: 0001127602-20-030120 · form4.xml · nonDerivative · entry 6 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,035 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.635 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 21:50 UTC |
Humphries William D.President, Ortho-Dermatologics
|
Exercise / conversionCommon Shares, No Par Value | 13,663 | $14.38 | $196,473.94 |
DisclosureSEC source: 0001127602-20-030120 · form4.xml · nonDerivative · entry 5 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2020 Filed Nov 30, 2020 21:50 UTC |
Humphries William D.President, Ortho-Dermatologics
|
Exercise / conversionNon-qualified Stock Options (right To Purchase) · Derivative | 21,658 | $0.00 Strike: $14.38 | $0.00 |
DisclosureSEC source: 0001127602-20-030120 · form4.xml · derivative · entry 8 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,718 Underlying: Common Shares, No Par Value · 21,658 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| November 24, 2020 Filed Nov 30, 2020 21:50 UTC |
Humphries William D.President, Ortho-Dermatologics
|
SaleCommon Shares, No Par Value | 21,658 | $19.63 | $425,196.35 |
DisclosureSEC source: 0001127602-20-030120 · form4.xml · nonDerivative · entry 4 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,035 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.66 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote. Read SEC document |
| November 24, 2020 Filed Nov 30, 2020 21:50 UTC |
Humphries William D.President, Ortho-Dermatologics
|
Exercise / conversionCommon Shares, No Par Value | 21,658 | $14.38 | $311,442.04 |
DisclosureSEC source: 0001127602-20-030120 · form4.xml · nonDerivative · entry 2 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 30, 2020 21:50 UTC |
Humphries William D.President, Ortho-Dermatologics
|
Exercise / conversionNon-qualified Stock Options (right To Purchase) · Derivative | 1,483 | $0.00 Strike: $14.38 | $0.00 |
DisclosureSEC source: 0001127602-20-030120 · form4.xml · derivative · entry 7 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,376 Underlying: Common Shares, No Par Value · 1,483 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| November 23, 2020 Filed Nov 30, 2020 21:50 UTC |
Humphries William D.President, Ortho-Dermatologics
|
SaleCommon Shares, No Par Value | 1,483 | $19.63 | $29,115.44 |
DisclosureSEC source: 0001127602-20-030120 · form4.xml · nonDerivative · entry 3 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,035 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.64 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote. Read SEC document |
| November 23, 2020 Filed Nov 30, 2020 21:50 UTC |
Humphries William D.President, Ortho-Dermatologics
|
Exercise / conversionCommon Shares, No Par Value | 1,483 | $14.38 | $21,325.54 |
DisclosureSEC source: 0001127602-20-030120 · form4.xml · nonDerivative · entry 1 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 20:50 UTC |
Spurr RobertPresident, Salix
|
Tax withholdingCommon Shares, No Par Value | 276 | $15.89 | $4,385.64 |
DisclosureSEC source: 0001127602-20-026615 · form4.xml · nonDerivative · entry 1 Spurr Robert · CIK 0001543795 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,696 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:03 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 442 | $15.54 | $6,868.68 |
DisclosureSEC source: 0001127602-20-026312 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,171 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:03 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 2,413 | $15.54 | $37,498.02 |
DisclosureSEC source: 0001127602-20-026311 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,902 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:02 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,930 | $15.54 | $29,992.20 |
DisclosureSEC source: 0001127602-20-026308 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,998 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:01 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 2,171 | $15.54 | $33,737.34 |
DisclosureSEC source: 0001127602-20-026306 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,600 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 20:09 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
Tax withholdingCommon Shares, No Par Value | 5,115 | $15.91 | $81,379.65 |
DisclosureSEC source: 0001127602-20-025186 · form4.xml · nonDerivative · entry 2 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 799,865 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 20:06 UTC |
Herendeen PaulEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 1,642 | $15.91 | $26,124.22 |
DisclosureSEC source: 0001127602-20-025184 · form4.xml · nonDerivative · entry 1 Herendeen Paul · CIK 0001374175 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,611 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 20:09 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
Tax withholdingCommon Shares, No Par Value | 3,623 | $15.40 | $55,794.20 |
DisclosureSEC source: 0001127602-20-025186 · form4.xml · nonDerivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 804,980 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 20:34 UTC |
Humphries William D.President, Ortho-Dermatologics
|
SaleCommon Shares, No Par Value | 5,667 | $16.17 | $91,635.39 |
DisclosureSEC source: 0001127602-20-024896 · form4.xml · nonDerivative · entry 1 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,035 F1 · kind: The sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 22:50 UTC |
Spurr RobertPresident, Salix
|
Tax withholdingCommon Shares, No Par Value | 1,278 | $17.00 | $21,726.00 |
DisclosureSEC source: 0001127602-20-024487 · form4.xml · nonDerivative · entry 1 Spurr Robert · CIK 0001543795 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,972 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 22:44 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
GrantCommon Shares, No Par Value | 28,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-024485 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,196 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 23:12 UTC |
Humphries William D.President, Ortho-Dermatologics
|
Tax withholdingCommon Shares, No Par Value | 4,567 | $17.48 | $79,831.16 |
DisclosureSEC source: 0001127602-20-023930 · form4.xml · nonDerivative · entry 1 Humphries William D. · CIK 0001674278 · President, Ortho-Dermatologics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,702 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:39 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 375 | $18.29 | $6,858.75 |
DisclosureSEC source: 0001127602-20-020938 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,729 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:35 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 2,050 | $18.29 | $37,494.50 |
DisclosureSEC source: 0001127602-20-020927 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,489 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:30 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,545 | $18.29 | $28,258.05 |
DisclosureSEC source: 0001127602-20-020914 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,068 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:25 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,750 | $18.29 | $32,007.50 |
DisclosureSEC source: 0001127602-20-020902 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,429 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:24 UTC |
ValueAct Holdings, L.P.Director · See Remarks
ValueAct Capital Master Fund, L.P.Director · See Remarks
ValueAct Co-Invest Master Fund, L.P.Director · See Remarks
VA Partners I, LLCDirector · See Remarks
ValueAct Capital Management, L.P.Director · See Remarks
ValueAct Capital Management, LLCDirector · See Remarks
ValueAct Holdings II, L.P.Director · See Remarks
ValueAct Holdings GP, LLCDirector · See Remarks
|
PurchaseCommon Shares, no par value | 948,353 | $19.24 | $18,246,311.72 |
DisclosureSEC source: 0001418812-20-000049 · primary_doc.xml · nonDerivative · entry 2 ValueAct Holdings, L.P. · CIK 0001418814 · Director · See Remarks ValueAct Capital Master Fund, L.P. · CIK 0001464912 · Director · See Remarks ValueAct Co-Invest Master Fund, L.P. · CIK 0001579734 · Director · See Remarks VA Partners I, LLC · CIK 0001418812 · Director · See Remarks ValueAct Capital Management, L.P. · CIK 0001351069 · Director · See Remarks ValueAct Capital Management, LLC · CIK 0001351073 · Director · See Remarks ValueAct Holdings II, L.P. · CIK 0001763309 · Director · See Remarks ValueAct Holdings GP, LLC · CIK 0001418813 · Director · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 17,931,594 F1 · kind: The securities were transferred in an internal restructuring resulting in the transfer of the direct ownership of the shares reported herein (the "Restructuring"). In connection with the Restructuring, ValueAct Co-Invest Master Fund, L.P. transferred in a private transaction 948,353 of its shares to ValueAct Capital Master Fund, L.P. The Restructuring did not constitute a change in the aggregate number of shares beneficially owned by the reporting persons. The transaction was effected at the closing market price on the transaction date. F2 · ownership.nature: Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F4 · ownership.nature: The securities reported herein are directly beneficially owned by ValueAct Capital Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings II, L.P. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:24 UTC |
ValueAct Holdings, L.P.Director · See Remarks
ValueAct Capital Master Fund, L.P.Director · See Remarks
ValueAct Co-Invest Master Fund, L.P.Director · See Remarks
VA Partners I, LLCDirector · See Remarks
ValueAct Capital Management, L.P.Director · See Remarks
ValueAct Capital Management, LLCDirector · See Remarks
ValueAct Holdings II, L.P.Director · See Remarks
ValueAct Holdings GP, LLCDirector · See Remarks
|
SaleCommon Shares, no par value | 948,353 | $19.24 | $18,246,311.72 |
DisclosureSEC source: 0001418812-20-000049 · primary_doc.xml · nonDerivative · entry 1 ValueAct Holdings, L.P. · CIK 0001418814 · Director · See Remarks ValueAct Capital Master Fund, L.P. · CIK 0001464912 · Director · See Remarks ValueAct Co-Invest Master Fund, L.P. · CIK 0001579734 · Director · See Remarks VA Partners I, LLC · CIK 0001418812 · Director · See Remarks ValueAct Capital Management, L.P. · CIK 0001351069 · Director · See Remarks ValueAct Capital Management, LLC · CIK 0001351073 · Director · See Remarks ValueAct Holdings II, L.P. · CIK 0001763309 · Director · See Remarks ValueAct Holdings GP, LLC · CIK 0001418813 · Director · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: The securities were transferred in an internal restructuring resulting in the transfer of the direct ownership of the shares reported herein (the "Restructuring"). In connection with the Restructuring, ValueAct Co-Invest Master Fund, L.P. transferred in a private transaction 948,353 of its shares to ValueAct Capital Master Fund, L.P. The Restructuring did not constitute a change in the aggregate number of shares beneficially owned by the reporting persons. The transaction was effected at the closing market price on the transaction date. F2 · ownership.nature: Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F3 · ownership.nature: The securities reported herein are directly beneficially owned by ValueAct Co-Invest Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Co-Invest Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Co-Invest Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings II, L.P. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 585,100 | $15.92 | $9,314,792.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 12 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 25,839,035 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 624,900 | $15.87 | $9,917,163.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 11 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 25,253,935 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 70,000 | $15.65 | $1,095,500.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 10 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 24,629,035 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 348,920 | $15.85 | $5,530,382.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 9 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 24,559,035 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 645,844 | $16.70 | $10,785,594.80 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 8 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 24,210,115 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 80,300 | $16.58 | $1,331,374.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 7 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 23,564,271 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 603,900 | $16.32 | $9,855,648.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 6 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 23,483,971 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 799,900 | $17.24 | $13,790,276.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 5 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 22,880,071 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 678,400 | $17.47 | $11,851,648.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 4 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 22,080,171 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:25 UTC |
Paulson JohnDirector
|
PurchaseCommon Stock, no par value | 374,836 | $17.33 | $6,495,907.88 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 3 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 21,401,771 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.